Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

A case of refractory adult-onset Still's disease treated with anakinra.

Lahiri M, Teng GG.

Int J Rheum Dis. 2010 Aug;13(3):e36-41. doi: 10.1111/j.1756-185X.2010.01474.x.

PMID:
20704609
2.

Successful treatment of Schnitzler's syndrome with anakinra after failure of rituximab trial.

Cascavilla N, Bisceglia M, D'Arena G.

Int J Immunopathol Pharmacol. 2010 Apr-Jun;23(2):633-6.

PMID:
20646359
3.

Persistent pruritic papules and plaques: a characteristic histopathologic presentation seen in a subset of patients with adult-onset and juvenile Still's disease.

Fortna RR, Gudjonsson JE, Seidel G, Dicostanzo D, Jacobson M, Kopelman M, Patel RM.

J Cutan Pathol. 2010 Sep;37(9):932-7. doi: 10.1111/j.1600-0560.2010.01570.x. Epub 2010 Jun 10.

4.

Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: Results of a multicenter, phase II, dose-ranging study.

So A, De Meulemeester M, Pikhlak A, Yücel AE, Richard D, Murphy V, Arulmani U, Sallstig P, Schlesinger N.

Arthritis Rheum. 2010 Oct;62(10):3064-76. doi: 10.1002/art.27600.

5.

Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study).

Abbate A, Kontos MC, Grizzard JD, Biondi-Zoccai GG, Van Tassell BW, Robati R, Roach LM, Arena RA, Roberts CS, Varma A, Gelwix CC, Salloum FN, Hastillo A, Dinarello CA, Vetrovec GW; VCU-ART Investigators..

Am J Cardiol. 2010 May 15;105(10):1371-1377.e1. doi: 10.1016/j.amjcard.2009.12.059. Epub 2010 Apr 2.

PMID:
20451681
6.

Modern approaches to the diagnosis and treatment of cold contact urticaria.

Krause K, Zuberbier T, Maurer M.

Curr Allergy Asthma Rep. 2010 Jul;10(4):243-9. doi: 10.1007/s11882-010-0121-3.

PMID:
20446123
7.

Altered redox state of monocytes from cryopyrin-associated periodic syndromes causes accelerated IL-1beta secretion.

Tassi S, Carta S, Delfino L, Caorsi R, Martini A, Gattorno M, Rubartelli A.

Proc Natl Acad Sci U S A. 2010 May 25;107(21):9789-94. doi: 10.1073/pnas.1000779107. Epub 2010 May 5.

8.

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.

Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nuñez G, Schnurr M, Espevik T, Lien E, Fitzgerald KA, Rock KL, Moore KJ, Wright SD, Hornung V, Latz E.

Nature. 2010 Apr 29;464(7293):1357-61. doi: 10.1038/nature08938. Erratum in: Nature. 2010 Jul 29;466(7306):652.

9.

Monogenic IL-1 mediated autoinflammatory and immunodeficiency syndromes: finding the right balance in response to danger signals.

Henderson C, Goldbach-Mansky R.

Clin Immunol. 2010 May;135(2):210-22. doi: 10.1016/j.clim.2010.02.013. Epub 2010 Mar 30. Review.

10.

Otolaryngological manifestations of 'Muckle-Wells syndrome'.

Biswas D, Stafford N.

Int J Pediatr Otorhinolaryngol. 2010 May;74(5):553-5. doi: 10.1016/j.ijporl.2010.02.023. Epub 2010 Mar 17.

PMID:
20299111
11.

A somatic NLRP3 mutation as a cause of a sporadic case of chronic infantile neurologic, cutaneous, articular syndrome/neonatal-onset multisystem inflammatory disease: Novel evidence of the role of low-level mosaicism as the pathophysiologic mechanism underlying mendelian inherited diseases.

Aróstegui JI, Lopez Saldaña MD, Pascal M, Clemente D, Aymerich M, Balaguer F, Goel A, Fournier del Castillo C, Rius J, Plaza S, López Robledillo JC, Juan M, Ibañez M, Yagüe J.

Arthritis Rheum. 2010 Apr;62(4):1158-66. doi: 10.1002/art.27342.

12.

Rilonacept--CAPS and beyond.

Stahl N, Radin A, Mellis S.

Ann N Y Acad Sci. 2009 Dec;1182:124-34. doi: 10.1111/j.1749-6632.2009.05074.x. Review.

PMID:
20074281
13.

Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome.

Neven B, Marvillet I, Terrada C, Ferster A, Boddaert N, Couloignier V, Pinto G, Pagnier A, Bodemer C, Bodaghi B, Tardieu M, Prieur AM, Quartier P.

Arthritis Rheum. 2010 Jan;62(1):258-67. doi: 10.1002/art.25057.

14.

Autoinflammation: the prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses.

Goldbach-Mansky R, Kastner DL.

J Allergy Clin Immunol. 2009 Dec;124(6):1141-9; quiz 1150-1. doi: 10.1016/j.jaci.2009.11.016. Review.

15.

Cerebrospinal fluid neopterin and cryopyrin-associated periodic syndrome.

Serrano M, Ormazábal A, Antón J, Aróstegui JI, García-Cazorla A.

Pediatr Neurol. 2009 Dec;41(6):448-50. doi: 10.1016/j.pediatrneurol.2009.06.008.

PMID:
19931168
16.

Schnitzler's syndrome with prominent neutrophil infiltration misdiagnosed as Sweet's syndrome: a typical example of urticarial neutrophilic dermatosis.

Asahina A, Sakurai N, Suzuki Y, Narushima K.

Clin Exp Dermatol. 2010 Jun;35(4):e123-6. doi: 10.1111/j.1365-2230.2009.03746.x. Epub 2009 Nov 19.

PMID:
19925486
17.

Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra.

Brenner M, Ruzicka T, Plewig G, Thomas P, Herzer P.

Br J Dermatol. 2009 Nov;161(5):1199-201. doi: 10.1111/j.1365-2133.2009.09404.x. Epub 2009 Aug 10.

PMID:
19673875
18.

The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study.

Terkeltaub R, Sundy JS, Schumacher HR, Murphy F, Bookbinder S, Biedermann S, Wu R, Mellis S, Radin A.

Ann Rheum Dis. 2009 Oct;68(10):1613-7. doi: 10.1136/ard.2009.108936. Epub 2009 Jul 26.

19.

Interleukin-1 beta targeted therapy for type 2 diabetes.

Maedler K, Dharmadhikari G, Schumann DM, Størling J.

Expert Opin Biol Ther. 2009 Sep;9(9):1177-88. doi: 10.1517/14712590903136688. Review.

PMID:
19604125
20.

Neurological manifestations of the Mendelian-inherited autoinflammatory syndromes.

Montealegre Sanchez GA, Hashkes PJ.

Dev Med Child Neurol. 2009 Jun;51(6):420-8. doi: 10.1111/j.1469-8749.2009.03336.x. Review.

Supplemental Content

Support Center